CODX vs PH
Co-Diagnostics, Inc. Common Stock (CODX) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
CODX currently screens at market cap $31.4M. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the CODX and PH stock pages for the full models.
Not investment advice.